34
Participants
Start Date
November 24, 2020
Primary Completion Date
December 1, 2022
Study Completion Date
December 1, 2022
Lactobacillus reuteri Prodentis®-lozenges (DSM 17938, ATCC PTA 5289)
Supplementary intake of Lactobacillus reuteri Prodentis®-lozenges (DSM 17938, ATCC PTA 5289) 2 times per day for 12 weeks
Placebo-lozenges (BioGaia)
Placebo-lozenges (BioGaia) 2 times per day for 12 weeks
RECRUITING
UniversityHospitalErlangen-Nurenberg, Erlangen
Collaborators (1)
BioGaia AB
INDUSTRY
University of Erlangen-Nürnberg
OTHER